These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
| | |
Acquisitions
|
| | |
Top-Line Growth
|
| | |
Bottom-Line Results
|
| | |
Per Share Results
|
| |
| | |
$1.77B in total assets, a 137% increase from 2019
$1.3B of capital committed, a 107% increase from 2019
(1)
66 total properties, a 43% increase from 2019
|
| | |
$116.9M in total revenues, a 162% increase from 2019
|
| | |
$64.4M in net income attributable to common stockholders
$97.8M in adjusted funds from operations (“AFFO”), a 180% increase from 2019
(2)
|
| | |
$3.27 in net income attributable to common stockholders per share – diluted
$5.00 in AFFO per share – diluted, a 53% increase from 2019
(2)
|
| |
| | |
Total Stockholder Returns
(1)
|
| | |
Dividends
|
| | ||||||||||||
| | |
One Year
|
| | |
Two Years
|
| | |
Three Years
|
| | |
Four Years
|
| | ||||
| | |
151% one-year TSR
157% outperformance
over MSCI US REIT Index (4)(5)
133% outperformance
over S&P 500 (5) |
| | |
334% two-year TSR
312% outperformance
over MSCI US REIT Index (4)(5)
278% outperformance
over S&P 500 (5) |
| | |
529% three-year TSR
512% outperformance
over MSCI US REIT Index (4)(5)
480% outperformance
over S&P 500 (5) |
| | |
1,046% four-year TSR
1,020% outperformance
over MSCI US REIT Index (4)(5)
965% outperformance
over S&P 500 (5) |
| | |
$4.47 2020
Dividends
58% increase
from 2019 (2)
$1.24 Q4
2020 Dividend (3) |
| |
| |
Corporate Governance Highlights
|
| |||||||||
| | ✓ | | | Six directors, including four independent directors, one female director and one Mexican-American director. | | | ✓ | | | Our directors conduct annual self-evaluations and participate in orientation and continuing education programs. | |
| | ✓ | | | All directors subject to annual election. | | | ✓ | | | We annually submit our executive compensation to a “say-on-pay” advisory vote by our stockholders. | |
| | ✓ | | | All Board committee members are independent. | | | ✓ | | | We amended our bylaws to allow stockholders to propose amendments to our bylaws. | |
| | ✓ | | | Our directors, officers, and other employees are subject to a Code of Business Conduct and Ethics. | | | ✓ | | | The restricted stock and restricted stock unit awards for our named executive officers have “double-trigger” acceleration provisions. | |
| | ✓ | | | Our directors and executive officers are subject to anti-hedging and anti-pledging policies. | | | ✓ | | | Our Board conducts regular executive sessions of independent directors. | |
| | ✓ | | | Cash and equity incentive compensation is subject to a formal clawback policy. | | | ✓ | | | All directors attended 100% of Board and Board committee meetings in 2020, including nine Board meetings. | |
| | ✓ | | | No stockholder rights plan is in effect. | | | ✓ | | | No tax gross-up provisions. | |
| | | | | | 2 | | | |
| | | | | | 4 | | | |
| | | | | | 4 | | | |
| | | | | | 4 | | | |
| | | | | | 6 | | | |
| | | | | | 12 | | | |
| | | | | | 12 | | | |
| | | | | | 13 | | | |
| | | | | | 14 | | | |
| | | | | | 14 | | | |
| | | | | | 15 | | | |
| | | | | | 16 | | | |
| | | | | | 16 | | | |
| | | | | | 16 | | | |
| | | | | | 20 | | | |
| | | | | | 22 | | | |
| | | | | | 25 | | | |
| | | | | | 26 | | | |
| | | | | | 27 | | | |
| | | | | | 27 | | | |
| | | | | | 28 | | | |
| | | | | | 28 | | | |
| | | | | | 29 | | | |
| | | | | | 29 | | | |
| | | | | | 29 | | | |
| | | | | | 31 | | | |
| | | | | | 32 | | | |
| | | | | | 33 | | | |
| | | | | | 34 | | | |
| | | | | | 35 | | | |
| | | | | | 36 | | | |
| | | | | | 37 | | | |
| | | | | | 37 | | | |
| | | | | | 37 | | | |
| | | | | | 37 | | | |
| | | | | | 38 | | |
| | | | | | |
Alan
Gold |
| | |
Mary
Curran |
| | |
Gary
Kreitzer |
| | |
Scott
Shoemaker |
| | |
Paul
Smithers |
| | |
David
Stecher |
| | ||||||||||||||||||
| | | Extensive commercial real estate experience | | | | | | X | | | | | | | | | | | | | | X | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Relevant executive experience | | | | | | X | | | | | | | X | | | | | | | X | | | | | | | | | | | | | | X | | | | | | | | | | |
| | |
High level of financial and capital markets experience
|
| | | | | X | | | | | | | X | | | | | | | X | | | | | | | | | | | | | | | | | | | | | X | | | |
| | |
Deep understanding of potential medical applications for cannabis
|
| | | | | X | | | | | | | | | | | | | | | | | | | | | X | | | | | | | | | | | | | | | | | |
| | | Strong regulatory and legal knowledge | | | | | | | | | | | | | | | | | | | | X | | | | | | | | | | | | | | X | | | | | | | | | | |
| | | Risk oversight experience | | | | | | X | | | | | | | X | | | | | | | X | | | | | | | X | | | | | | | X | | | | | | | X | | | |
| |
Name
|
| |
Position
|
| |
Age
|
| |||
| | Alan Gold | | | Executive Chairman | | | | | 60 | | |
| | Gary Kreitzer | | | Vice Chairman | | | | | 66 | | |
| | Mary Curran | | | Director | | | | | 64 | | |
| | Scott Shoemaker | | | Director | | | | | 54 | | |
| | Paul Smithers | | | President, Chief Executive Officer and Director | | | | | 64 | | |
| | David Stecher | | | Director | | | | | 60 | | |
| |
Name
(1)
|
| |
Fees Earned or
Paid in Cash (2) |
| |
Stock Awards
(3)
|
| |
Total
|
| |||||||||
| | Gary Kreitzer | | | | $ | 105,000 | | | | | $ | 100,027 | | | | | $ | 205,027 | | |
| | Mary Curran | | | | | 50,000 | | | | | | 80,004 | | | | | | 130,004 | | |
| | Scott Shoemaker, M.D. | | | | | 55,000 | | | | | | 80,004 | | | | | | 135,004 | | |
| | David Stecher | | | | | 60,000 | | | | | | 80,004 | | | | | | 140,004 | | |
| | | | |
Audit Committee
|
| |
Compensation
Committee |
| |
Nominating and Corporate
Governance Committee |
|
| | Gary Kreitzer | | |
X
|
| |
Chair
|
| |
X
|
|
| | Mary Curran | | |
X
|
| | | | |
X
|
|
| | Scott Shoemaker, M.D. | | | | | |
X
|
| |
Chair
|
|
| | David Stecher | | |
Chair
|
| |
X
|
| | | |
| | Number of Meetings in 2020 | | |
4
|
| |
3
|
| |
2
|
|
| | | | |
2020
|
| |
2019
|
|
| | Audit Fees (1) | | |
$450
|
| |
$642
|
|
| | Audit Related Fees | | |
—
|
| |
—
|
|
| | Tax Fees | | |
82
|
| |
37
|
|
| | All Other Fees | | |
—
|
| |
—
|
|
| | Total | | |
$532
|
| |
$679
|
|
| |
Name
|
| |
Position
|
|
| | Alan Gold | | | Executive Chairman | |
| | Paul Smithers | | | President and Chief Executive Officer | |
| | Catherine Hastings | | | Chief Financial Officer and Treasurer | |
| | Brian Wolfe | | | Vice President, General Counsel and Secretary | |
| |
Executive
|
| |
2019 Annual
Base Salary |
| |
2020 Annual
Base Salary |
| |
Percentage Change
from 2019 to 2020 |
| |||||||||
| | Alan Gold | | | | $ | 650,000 | | | | | $ | 682,500 | | | | | | 5.0 % | | |
| | Paul Smithers | | | | | 400,000 | | | | | | 420,000 | | | | | | 5.0 % | | |
| | Catherine Hastings | | | | | 235,000 | | | | | | 246,750 | | | | | | 5.0 % | | |
| | Brian Wolfe | | | | | 230,000 | | | | | | 241,500 | | | | | | 5.0 % | | |
| |
Executive
|
| |
2020 Annual
Base Salary |
| |
2021 Annual
Base Salary |
| |
Percentage Change
from 2020 to 2021 |
| |||||||||
| | Alan Gold | | | | $ | 682,500 | | | | | $ | 1,023,750 | | | | | | 50.0 % | | |
| | Paul Smithers | | | | | 420,000 | | | | | | 840,000 | | | | | | 100.0 % | | |
| | Catherine Hastings | | | | | 246,750 | | | | | | 308,500 | | | | | | 25.0 % | | |
| | Brian Wolfe | | | | | 241,500 | | | | | | 295,000 | | | | | | 22.2 % | | |
| |
Executive
|
| |
2020
Restricted Stock (1) |
| |
2020
RSUs (1) |
| |
2021
Restricted Stock (2) |
| |
2021
RSUs (2) |
| ||||||||||||
| | Alan Gold | | | | | — | | | | | | 15,978 | | | | | | — | | | | | | 12,612 | | |
| | Paul Smithers | | | | | — | | | | | | 10,653 | | | | | | — | | | | | | 6,654 | | |
| | Catherine Hastings | | | | | — | | | | | | 7,323 | | | | | | — | | | | | | 2,607 | | |
| | Brian Wolfe | | | | | 6,657 | | | | | | — | | | | | | 2,553 | | | | | | — | | |
| |
The Company’s TSR Ranking within the Two Comparator Groups
|
| |
PSU Payout (as a % of Target)
|
|
| |
At or above 80th percentile TSR
|
| |
150%
|
|
| |
Between the 80th percentile TSR and 55th percentile TSR
|
| |
Determined by linear interpolation
(1)
|
|
| |
At the 55th percentile TSR
|
| |
100%
|
|
| |
Between the 25th percentile TSR and 55th percentile TSR
|
| |
Determined by linear interpolation
(2)
|
|
| |
At or below the 25th percentile TSR
|
| |
0%
|
|
| |
Executive
|
| |
2021 Target PSUs
|
| |||
| | Alan Gold | | | | | 31,857 | | |
| | Paul Smithers | | | | | 21,238 | | |
| | Catherine Hastings | | | | | 8,496 | | |
| | Brian Wolfe | | | | | 7,080 | | |
| |
Name and Principal Position
|
| |
Year
|
| |
Salary
|
| |
Bonus
|
| |
Stock
Awards |
| |
All Other
Compensation (1) |
| |
Total
|
| ||||||||||||||||||
| |
Alan Gold
Executive Chairman |
| | | | 2020 | | | | | $ | 682,500 | | | | | $ | 1,535,625 | | | | | $ | 1,200,108 (2 ) | | | | | $ | 8,550 | | | | | $ | 3,426,783 | | |
| | | | 2019 | | | | | | 650,000 | | | | | | 1,300,000 | | | | | | 900,077 (3 ) | | | | | | 8,400 | | | | | | 2,858,477 | | | |||
| | | | 2018 | | | | | | 600,000 | | | | | | 800,000 | | | | | | 1,200,058 (4 ) | | | | | | 8,250 | | | | | | 2,608,308 | | | |||
| |
Paul Smithers
President and Chief Executive Officer |
| | | | 2020 | | | | | | 420,000 | | | | | | 630,000 | | | | | | 800,147 (2 ) | | | | | | 8,550 | | | | | | 1,858,697 | | |
| | | | 2019 | | | | | | 400,000 | | | | | | 400,000 | | | | | | 600,157 (3 ) | | | | | | 8,400 | | | | | | 1,408,557 | | | |||
| | | | 2018 | | | | | | 360,000 | | | | | | 360,000 | | | | | | 350,043 (4 ) | | | | | | 8,250 | | | | | | 1,078,293 | | | |||
| |
Catherine Hastings
Chief Financial Officer and Treasurer |
| | | | 2020 | | | | | | 246,750 | | | | | | 370,125 | | | | | | 550,031 (2 ) | | | | | | 8,550 | | | | | | 1,175,456 | | |
| | | | 2019 | | | | | | 235,000 | | | | | | 235,000 | | | | | | 400,104 (3 ) | | | | | | 8,400 | | | | | | 878,504 | | | |||
| | | | 2018 | | | | | | 210,000 | | | | | | 210,000 | | | | | | 200,024 (4 ) | | | | | | 8,250 | | | | | | 628,274 | | | |||
| |
Brian Wolfe
Vice President, General Counsel and Secretary |
| | | | 2020 | | | | | | 241,500 | | | | | | 362,250 | | | | | | 500,007 (2 ) | | | | | | 8,550 | | | | | | 1,112,307 | | |
| | | | 2019 | | | | | | 230,000 | | | | | | 230,000 | | | | | | 400,104 (3 ) | | | | | | 8,400 | | | | | | 868,504 | | | |||
| | | | 2018 | | | | | | 210,000 | | | | | | 210,000 | | | | | | 200,024 (4 ) | | | | | | 8,250 | | | | | | 628,274 | | | |||
| | | | |
Grant Date
|
| |
All Other Stock Awards:
Number of Shares of Stock or Units (1) |
| |
Grant Date Fair
Value of Stock Awards (2) |
| ||||||
| | Alan Gold | | |
January 3, 2020
|
| | | | 15,978 | | | | | $ | 1,200,108 | | |
| | Paul Smithers | | |
January 3, 2020
|
| | | | 10,653 | | | | | | 800,147 | | |
| | Catherine Hastings | | |
January 3, 2020
|
| | | | 7,323 | | | | | | 550,031 | | |
| | Brian Wolfe | | |
January 3, 2020
|
| | | | 6,657 | | | | | | 500,007 | | |
| | | | |
Stock Awards
|
| |||||||||
| |
Name
|
| |
Number of
Shares or Units of Stock That Have Not Vested (#) (1) |
| |
Market Value of
Shares or Units of Stock That Have Not Vested ($) (1) |
| ||||||
| | Alan Gold | | | | | 40,917 (2 ) | | | | | $ | 7,493,130 | | |
| | Paul Smithers | | | | | 22,187 (3 ) | | | | | | 4,063,105 | | |
| | Catherine Hastings | | | | | 14,635 (4 ) | | | | | | 2,680,108 | | |
| | Brian Wolfe | | | | | 13,969 (5 ) | | | | | | 2,558,143 | | |
| | | | |
Stock Awards
|
| |||||||||
| |
Name
|
| |
Number of Shares or
Units Acquired on Vesting (#) (1) |
| |
Value Realized on
Vesting ($) (2) |
| ||||||
| | Alan Gold | | | | | 40,674 | | | | | $ | 3,085,936 | | |
| | Paul Smithers | | | | | 13,369 | | | | | | 1,014,306 | | |
| | Catherine Hastings | | | | | 7,063 | | | | | | 535,870 | | |
| | Brian Wolfe | | | | | 7,643 | | | | | | 579,874 | | |
| |
Named Executive Officer and Trigger
|
| |
Severance
Payments (1) |
| |
Medical
Benefits (2) |
| |
Value of
Accelerated Equity Awards (3) |
| |
Total
|
| ||||||||||||
| | Alan Gold | | | | | | | | | | | | | | | | | | | | | | | | | |
| |
Qualifying Termination (other than within two years of a
“change of control”) |
| | | $ | 5,683,125 | | | | | $ | 40,474 | | | | | $ | 5,993,258 | | | | | $ | 11,716,857 | | |
| |
Qualifying Termination (within two years of a “change of
control”) |
| | | | 5,683,125 | | | | | | 40,474 | | | | | | 7,493,130 | | | | | | 13,216,729 | | |
| | Qualifying Retirement | | | | | — | | | | | | — | | | | | | 7,493,130 | | | | | | 7,493,130 | | |
| | Death | | | | | — | | | | | | — | | | | | | 7,493,130 | | | | | | 7,493,130 | | |
| | Disability | | | | | — | | | | | | — | | | | | | 7,493,130 | | | | | | 7,493,130 | | |
| | Paul Smithers | | | | | | | | | | | | | | | | | | | | | | | | | |
| |
Qualifying Termination (other than within two years of a
“change of control”) |
| | | $ | 2,650,000 | | | | | $ | 76,652 | | | | | $ | 3,063,934 | | | | | $ | 5,790,586 | | |
| |
Qualifying Termination (within two years of a “change of
control”) |
| | | | 2,650,000 | | | | | | 76,652 | | | | | | 4,063,105 | | | | | | 6,789,757 | | |
| | Qualifying Retirement | | | | | — | | | | | | — | | | | | | 4,063,105 | | | | | | 4,063,105 | | |
| | Death | | | | | — | | | | | | — | | | | | | 4,063,105 | | | | | | 4,063,105 | | |
| | Disability | | | | | — | | | | | | — | | | | | | 4,063,105 | | | | | | 4,063,105 | | |
| | Catherine Hastings | | | | | | | | | | | | | | | | | | | | | | | | | |
| |
Qualifying Termination (other than within two years of a
“change of control”) |
| | | $ | 1,036,917 | | | | | $ | 55,849 | | | | | $ | 1,998,232 | | | | | $ | 3,090,998 | | |
| |
Qualifying Termination (within two years of a “change of
control”) |
| | | | 1,036,917 | | | | | | 55,849 | | | | | | 2,680,108 | | | | | | 3,772,874 | | |
| | Qualifying Retirement | | | | | — | | | | | | — | | | | | | 2,680,108 | | | | | | 2,680,108 | | |
| | Death | | | | | — | | | | | | — | | | | | | 2,680,108 | | | | | | 2,680,108 | | |
| | Disability | | | | | — | | | | | | — | | | | | | 2,680,108 | | | | | | 2,680,108 | | |
| | Brian Wolfe | | | | | | | | | | | | | | | | | | | | | | | | | |
| |
Qualifying Termination (other than within two years of a
“change of control”) |
| | | $ | 1,017,833 | | | | | $ | 47,816 | | | | | $ | 1,923,956 | | | | | $ | 2,989,605 | | |
| |
Qualifying Termination (within two years of a “change of
control”) |
| | | | 1,017,833 | | | | | | 47,816 | | | | | | 2,558,143 | | | | | | 3,623,792 | | |
| | Qualifying Retirement | | | | | — | | | | | | — | | | | | | 2,558,143 | | | | | | 2,558,143 | | |
| | Death | | | | | — | | | | | | — | | | | | | 2,558,143 | | | | | | 2,558,143 | | |
| | Disability | | | | | — | | | | | | — | | | | | | 2,558,143 | | | | | | 2,558,143 | | |
| |
Plan Category
|
| |
Number of Securities
to be Issued Upon Exercise of Outstanding Options, Warrants and Rights |
| |
Weighted Average
Exercise Price of Outstanding Options, Warrants and Rights |
| |
Number of Securities
Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in First Column) |
|
| |
Equity compensation plans approved by stockholders
(1)
|
| |
36,687
|
| |
—
|
| |
723,265
|
|
| |
Equity compensation plans not approved by stockholders
|
| |
—
|
| |
—
|
| |
—
|
|
| |
Total
|
| |
—
|
| |
—
|
| |
723,265
|
|
| |
Name of Beneficial Owner
|
| |
Number of Shares
Beneficially Owned |
| |
Percent of
All Shares (1) |
| ||||||
| | Alan Gold (2) | | | | | 337,284 | | | | | | 1.4 % | | |
| | Gary Kreitzer (3) | | | | | 36,714 | | | | | | * | | |
| | Paul Smithers (4) | | | | | 31,740 | | | | | | * | | |
| | Catherine Hastings (5) | | | | | 13,005 | | | | | | * | | |
| | Brian Wolfe (6) | | | | | 9,515 | | | | | | * | | |
| | Scott Shoemaker (7) | | | | | 3,060 | | | | | | * | | |
| | David Stecher (8) | | | | | 5,720 | | | | | | * | | |
| | Mary Curran (9) | | | | | 2,360 | | | | | | * | | |
| | All directors and officers as a group (eight persons) | | | | | 439,398 | | | | | | 1.8 % | | |
| | BlackRock, Inc. (10) | | | | | 3,806,926 | | | | | | 15.9 % | | |
| | Vanguard Group, Inc. (11) | | | | | 3,386,069 | | | | | | 14.2 % | | |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|